Rule 10.58.312 - INITIAL CLINICAL PARTNERSHIPS AND PRACTICE(1) The provider: (a) ensures that effective partnerships and high-quality clinical practice in different settings and modalities are central to preparation so that candidates develop the knowledge, skills, and professional dispositions necessary to demonstrate positive impact on all P-12 students' learning and development;(b) co-constructs mutually beneficial P-12 school and community arrangements for clinical preparation and share responsibility for continuous improvement of candidate preparation by: (i) ensuring partnerships for clinical preparation follow a range of forms, participants, and functions;(ii) establishing mutually agreeable expectations for candidate entry, preparation, and exit;(iii) ensuring that theory and practice are linked by maintaining coherence across clinical and academic components of preparation;(iv) sharing accountability for candidate outcomes; and(v) to the extent possible, providing opportunities for candidates to student teach in the district and school of their choice, including through recruitment and retention programs adopted by school districts, in accordance with statewide agreements among providers;(c) ensures that partners co-select, prepare, evaluate, and support high-quality clinical educators, both provider and school-based, who demonstrate a positive impact on candidates' development and P-12 student learning and development; and(d) works with partners to design and implement clinical experiences, utilizing various modalities of sufficient depth, breadth, diversity, coherence, and duration to ensure that candidates demonstrate their developing effectiveness and positive impact on all students' learning and development. Clinical experiences are structured to have multiple performance-based assessments at key points within the program to demonstrate candidates' development of the knowledge, skills, and professional dispositions, as delineated in ARM 10.58.311.Mont. Admin. r. 10.58.312
NEW, 2014 MAR p. 2936, Eff. 12/12/14; AMD, 2023 MAR p. 86, Eff. 7/1/2023AUTH: 20-2-114, MCA; IMP: 20-2-121, MCA